Labshake search
Citations for HansaBioMed :
1 - 16 of 16 citations since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2024Quote: Size exclusion chromatography column PURE-EVs (HansaBioMed Life Sciences) was equilibrated with PBS ...
-
bioRxiv - Cell Biology 2024Quote: ... referred to as COLO mEVs (Lyophilized Microvesicles from COLO1 cell line; HansaBioMed Life Sciences), were used for staining with fluorescent antibodies.
-
bioRxiv - Cell Biology 2024Quote: ... referred to as COLO sEVs (Lyophilized Exosomes from COLO1 cell line; HansaBioMed Life Sciences, Estonia), and medium size EVs ...
-
bioRxiv - Cell Biology 2024Quote: Commercially available EVs derived from HEK293 cell line overexpressing CD63-EGFP (FLuoEVs; HansaBioMed Life Sciences) were used for direct analyses on FNTA to define the traces-to-particles (T:P ...
-
bioRxiv - Biophysics 2024Quote: ... anti-CD63 (1:1000, HansaBiomed), anti-CD81 (1:1000 ...
-
bioRxiv - Bioengineering 2023Quote: ... SEC elution was performed using PURE-EVs SEC columns (HBM-PEV, HansaBioMed Life Sciences, Tallinn, Estonia) following the manufacturer’s protocol ...
-
bioRxiv - Cancer Biology 2023Quote: ... an in-house sandwich enzyme linked immunoassay (ELISA) kit (HansaBioMed Life Sciences), following the manufacturer’s protocol provided with the kit ...
-
bioRxiv - Cancer Biology 2023Quote: ... a black 96-well microplate with no binding capacity[(HansaBioMed Life Sciences) and Quant-iT™ RiboGreen™ RNA reagent (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: The lipid content of HEK nsEVs after incubation with PBS or carbonate buffer was quantified using a Cholesterol assay (Hansabiomed Life Sciences, Estonia). For this purpose ...
-
bioRxiv - Bioengineering 2021Quote: The EV isolation followed the protocol provided by the column manufacturer (PURE-EVs, HansaBioMed, Estonia). Briefly ...
-
bioRxiv - Cell Biology 2021Quote: ... the EV containing supernatant was filtered (0.45 μm) and transferred to TFF-Easy 20 kDa MWCO (HansaBioMed/Lonza, Tallinn, Estonia) for EV concentration ...
-
bioRxiv - Cell Biology 2021Quote: ... The EVs concentration process was described in the manufacture’s protocol (HansaBioMed/Lonza) and EVs were finally diafiltrated in RNase-free PBS.
-
bioRxiv - Synthetic Biology 2020Quote: Nanoparticle tracking analysis (NTA): 1 μL A549 EVs (1 mg/ml; #HBM-A549-100/5, HansaBioMed, Tallinn, Estonia) were diluted (1:1000 ...
-
bioRxiv - Synthetic Biology 2020Quote: ... Several A549 EV samples were setup and included the following components: 25 μl of A549 EVs (25 μg; #HBM-A549-100/5, HansaBioMed, Tallinn, Estonia) were incubated with 20 μl of Exosome-Human CD63 Dynabeads (#10606D ...
-
bioRxiv - Synthetic Biology 2020Quote: ... A549 EVs (100 μg; #HBM-A549-100/5, HansaBioMed, Tallinn, Estonia) were lysed and processed according to the manufacturer’s guidelines and the developed dot blot array was imaged using a ChemiDoc imaging system (Bio-Rad Laboratories Inc. ...
-
bioRxiv - Synthetic Biology 2020Quote: ... 0 or 50 μg of A549 EVs (0 or 50 μl; #HBM-A549-100/5, HansaBioMed, Tallinn, Estonia), 4 μl of cOmplete™ EDTA-free protease inhibitor cocktail (50X ...